GUFIC BIOSCIENCES
|
The Current P/S Ratio of GUFIC BIOSCIENCES is 5.07.
Share Price | ₹406.4 | Jan 28,2025 |
Market Cap | ₹4,076.2 Cr | |
Sales-TTM | ₹803.8 Cr | TTM-Standalone Results |
Price/Sales | 5.07x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of GUFIC BIOSCIENCES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹4,076.2 Cr] as on Jan 28,2025
(/) Sales [ ₹803.8 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 5.07x ]
Thus, for GUFIC BIOSCIENCES , the investors are currently willing to pay '5.07 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of GUFIC BIOSCIENCES !
The chart below summarizes the trend in P/S Ratio of GUFIC BIOSCIENCES over the last five years.
Historical PS (Price/Sales) ratio chart of GUFIC BIOSCIENCES
PS Ratio Performance Analysis for GUFIC BIOSCIENCES
- GUFIC BIOSCIENCES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 2.54x.
- GUFIC BIOSCIENCES 's operated at median p/e ratio of 2.62x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, GUFIC BIOSCIENCES 's p/e ratio peaked in Mar2024 at 3.52x.
- GUFIC BIOSCIENCES 's p/e ratio hit its five-year low in Mar2020 of 1.21x.
How does GUFIC BIOSCIENCES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
GUFIC BIOSCIENCES | 803.8 | 5.07 | 4,076.2 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 50,307.7 | 8.14 | 409,303.0 |
CIPLA LTD | 26,981.2 | 4.25 | 114,645.0 |
DR REDDYS LABORATORIES LTD | 31,229.3 | 3.15 | 98,449.5 |
ZYDUS LIFESCIENCES LTD | 21,483.5 | 4.26 | 91,587.4 |
DIVIS LABORATORIES LTD | 8,614.0 | 16.65 | 143,389.0 |
MANKIND PHARMA LTD | 11,641.0 | 8.71 | 101,440.0 |
TORRENT PHARMACEUTICALS LTD | 11,302.0 | 9.92 | 112,169.0 |
LUPIN LTD | 21,431.3 | 4.31 | 92,321.3 |
AUROBINDO PHARMA LTD | 30,295.0 | 2.18 | 66,080.7 |
ABBOTT INDIA LTD | 6,066.1 | 9.02 | 54,708.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs GUFIC BIOSCIENCES 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.18x |
Max industry PS | 16.65x |
Median industry PS | 5.07x |
Average industry PS | 6.88x |
You may also like the below Video Courses